Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia

被引:26
|
作者
Westermeier, Francisco [1 ,2 ]
Puebla, Carlos [1 ,2 ]
Luis Vega, Jose [1 ,2 ]
Farias, Marcelo [1 ,2 ]
Escudero, Carlos [1 ,2 ,3 ]
Casanello, Paola [1 ,2 ]
Sobrevia, Luis [1 ,2 ]
机构
[1] Pontificia Univ Catolica Chile, CMPL, Dept Obstet & Gynaecol, Med Res Ctr CIM,Sch Med,Fac Med, Santiago, Chile
[2] Pontificia Univ Catolica Chile, PRL, Dept Obstet & Gynaecol, Med Res Ctr CIM,Sch Med,Fac Med, Santiago, Chile
[3] Univ Bio Bio, Fac Sci, Dept Basic Sci, Chillan, Chile
关键词
Diabetes; gestational diabetes; nucleoside; transport; human; endothelium; UMBILICAL VEIN ENDOTHELIUM; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; SENSITIVE ADENOSINE TRANSPORT; GLUT1; GLUCOSE-TRANSPORTER; SLC29A1 PROMOTER ACTIVITY; RAT CARDIAC FIBROBLASTS; GLYCATION END-PRODUCTS; CATIONIC AMINO-ACIDS;
D O I
10.2174/157016109789043900
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetes mellitus types 1 and 2, and gestational diabetes are characterized by abnormal D-glucose metabolism and hyperglycaemia, and induce foetal endothelial dysfunction with implications in adult life increasing the risk of vascular diseases. Synthesis of nitric oxide (NO) and uptake of L-arginine (i.e. the L-arginine/NO signalling pathway) and adenosine (a vasoactive endogenous nucleoside) by the umbilical vein endothelium is altered in pathological pregnancies, including pregnancies with pre-established diabetes mellitus or in gestational diabetes. The mechanisms underlying these alterations include differential expression of equilibrative nucleoside transporters (ENTs), amino acid transporters and NO synthases (NOS). Modulation of ENTs and NOS expression and activity in endothelium involves several signalling molecules, including protein kinase C, mitogen-activated protein kinases p42 and p44, calcium and phosphatidyl inositol 3 kinase. Elevated extracellular D-glucose and diabetes alters human endothelial function. However, information regarding modulation the transport capacity as well as expression of ENTs is limited. This review focuses on the effect of diabetes mellitus and gestational diabetes, and hyperglycaemia on the reported mechanisms described for transcriptional and post-transcriptional regulation of ENTs, and the potential consequences for foetal endothelial function in these pathologies. Recent available information regarding functional consequences of an abnormal environment on the functionality of the endothelium from microvasculature of the human placenta is mentioned. The available information is scarce, but it could contribute to a better understanding of the cell and molecular basis of the altered vascular endothelial function in this pathological conditions, emphasizing the key role of this type of epithelium in fetal-placental function and the normal foetal development and growth.
引用
收藏
页码:435 / 449
页数:15
相关论文
共 50 条
  • [21] Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry
    Reyes, German
    Naydenova, Zlatina
    Abdulla, Parween
    Chalsev, Maria
    Villani, Anita
    Rose, Jennifer B.
    Chaudary, Naz
    DeSouza, Leroi
    Siu, K. W. Michael
    Coe, Imogen R.
    PROTEIN EXPRESSION AND PURIFICATION, 2010, 73 (01) : 1 - 9
  • [22] Diabetes mellitus in rats and hyperglycaemia in endothelial cells results in a diminished endothelial NO release
    Olbrich, A
    Zinn, M
    Salameh, A
    Dhein, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 165 - 165
  • [23] Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia
    Sobrevia, L
    Mann, GE
    EXPERIMENTAL PHYSIOLOGY, 1997, 82 (03) : 423 - 452
  • [24] Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2
    Miller, Siennah R.
    Hau, Raymond K.
    Jilek, Joseph L.
    Morales, Mark N.
    Wright, Stephen H.
    Cherrington, Nathan J.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (07) : 603 - 612
  • [25] INSULIN THERAPY RESTORES THE EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 EXPRESSION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS FROM GESTATIONAL DIABETES MELLITUS
    Silva, L.
    Subiabre, M.
    Villalobos-Labra, R.
    Salsoso, R.
    Lopez, A.
    Paulo, M.
    Pardo, F.
    Leiva, A.
    Sobrevia, L.
    PLACENTA, 2017, 51 : 130 - 130
  • [26] Functional characterization of cloned human equilibrative nucleoside transporters in nucleoside transport deficient cells
    Ward, JL
    Tse, CM
    GASTROENTEROLOGY, 1999, 116 (04) : A944 - A944
  • [27] Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides
    Endo, Yoshio
    Obata, Tohru
    Murata, Daigo
    Ito, Mariho
    Sakamoto, Kazuki
    Fukushima, Masakazu
    Yamasaki, Yasundo
    Yamada, Yuji
    Natsume, Nagato
    Sasaki, Takuma
    CANCER SCIENCE, 2007, 98 (10): : 1633 - 1637
  • [28] Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development
    Hau, Raymond K.
    Wright, Stephen H.
    Cherrington, Nathan J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 780 - 794
  • [29] The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters
    Aseervatham, Jaya
    Tran, Lucky
    Machaca, Khaled
    Boudker, Olga
    PLOS ONE, 2015, 10 (09):
  • [30] Functional expression of equilibrative and concentrative nucleoside transporters in alveolar epithelial cells
    Baba, S.
    Yumoto, R.
    Kawami, M.
    Takano, M.
    PHARMAZIE, 2021, 76 (09): : 416 - 421